APA (7th ed.) Citation

JD, H., JR, I., DR, S., ER, A., RV, B., & HA, B. (2011). A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma. Cancer Investigation, 29(7), 451.

Chicago Style (17th ed.) Citation

JD, Hainsworth, Infante JR, Spigel DR, Arrowsmith ER, Boccia RV, and Burris HA. "A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma." Cancer Investigation 29, no. 7 (2011): 451.

MLA (9th ed.) Citation

JD, Hainsworth, et al. "A Phase II Trial of Panobinostat, a Histone Deacetylase Inhibitor, in the Treatment of Patients with Refractory Metastatic Renal Cell Carcinoma." Cancer Investigation, vol. 29, no. 7, 2011, p. 451.